Evaluation of TP US in Women With Prolapse

Sponsor
Aljazeera Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03820089
Collaborator
Cairo University (Other)
100
1
11.9
8.4

Study Details

Study Description

Brief Summary

Many women suffers from uterine and vaginal prolapse Usually they suffer from these symotoms in menopause

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Ultrasonography TP

Detailed Description

The most common cause of pelvic organ prolapse is multiple pregnancy and multiparity

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of TP US Assesment of Women With Prolapse
Actual Study Start Date :
Jan 29, 2019
Actual Primary Completion Date :
Jan 20, 2020
Actual Study Completion Date :
Jan 25, 2020

Outcome Measures

Primary Outcome Measures

  1. The number of women who will be properly diagnosed with prolapse by TP us [within 2 months]

    The accuracy of TP US in diagnosing the prolapse

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 75 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women with history of normal delivery Age between 25 to 75 years
Exclusion Criteria:
  • women with cesarean deliveries

Contacts and Locations

Locations

Site City State Country Postal Code
1 Algazeerah and Kasralainy hospital Giza Egypt

Sponsors and Collaborators

  • Aljazeera Hospital
  • Cairo University

Investigators

  • Principal Investigator: Mahmoud Alalfy, PhD, Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aljazeera Hospital
ClinicalTrials.gov Identifier:
NCT03820089
Other Study ID Numbers:
  • prolapse
First Posted:
Jan 29, 2019
Last Update Posted:
Feb 10, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2022